Quantitative Evaluation of Cerenkov Luminescence for Imaging and Therapy
用于成像和治疗的切伦科夫发光的定量评估
基本信息
- 批准号:8342753
- 负责人:
- 金额:$ 34.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:90YAddressAlgorithmsAnimal ExperimentsAnimalsBiologicalBioluminescenceCathetersCellsCharacteristicsChargeClinicComplexCoupledDataDependenceDetectionDevelopmentDevicesDiagnostic ImagingDimensionsDiscipline of Nuclear MedicineDoseDrug Delivery SystemsElectronsEquationEyeFoundationsGamma RaysGoalsGoldHalf-LifeHybridsImageImaging TechniquesIn VitroLabelLasersLightLuciferasesMalignant neoplasm of liverMeasurableMeasurementMeasuresMedical ImagingMethodsMicrospheresNon-Hodgkin&aposs LymphomaNuclearOpticsOral cavityOutcomePathway interactionsPerformancePhotochemotherapyPhotonsPhototherapyPositronPositron-Emission TomographyProductionPropertyPublicationsQuantitative EvaluationsQuantum DotsRadiationRadioimmunotherapyRadioisotopesReporterResearchSideSignal TransductionSkinSourceSpatial DistributionSpeedSurfaceSystemTechniquesTechnologyTherapeuticTherapeutic community techniqueTimeTissuesTracerVisible RadiationWeightWorkbasecharge coupled device cameracomputer studiescostdensitydesignimaging modalityimprovedin vivoindexinginterestluminescencemagnetic fieldmolecular imagingmultimodalityoptical imagingparticlephotoactivationpre-clinicalpreclinical studyradiotracerreconstructionresearch studysimulationsingle photon emission computed tomographytheoriestomographyuptake
项目摘要
DESCRIPTION (provided by applicant): Cerenkov radiation is a phenomenon in which optical photons are emitted when a charged particle moves faster than the speed of light in a dielectric medium such as tissue. Recently we, and others, have discovered that measurable visible light due to the Cerenkov effect is produced in vivo following administration of ?-emitting radionuclides to small animals. Furthermore, the amounts of injected activity required to produce a detectable signal are consistent with small animal molecular imaging applications. This observation has led to the development of a new hybrid molecular imaging modality known as Cerenkov luminescence imaging (CLI) that allows the spatial distribution of biomolecules labeled with ?-emitting radionuclides to be imaged in vivo using sensitive charge-coupled device (CCD) cameras. This is especially valuable for preclinical studies with important therapeutic ?-emitting radionuclides, such as 90Y, that cannot readily be imaged at tracer doses using any other in vivo imaging technique. CLI also provides a fast, low-cost, readily accessible approach to image PET radiotracers in small animals. Translational opportunities for Cerenkov luminescence also exist. CLI might be possible for skin, eye and oral cavity, or using endoscopic or catheter-based devices inside the body. Another possible application that is being explored is to use the abundant blue/UV Cerenkov light produced by radiotracers as a source of internal light delivery deep inside tissues for photoactivation, for example in photodynamic therapy and photoactivated drug delivery. The goal of this proposal is to provide a quantitative understanding of Cerenkov luminescence as it applies to biomedical applications and to produce data that serves as a platform for guiding the development of small-animal and translational Cerenkov applications by the molecular imaging and therapeutics community. The specific aims address obtaining a detailed quantitative understanding of Cerenkov signals and spectra that can be measured from tissues through a combination of computation/simulation, phantom experiments and in vivo studies. We will compare the performance of two different camera technologies for the detection of weak Cerenkov signals, and determine detection limits. The ability to exploit spectral information for Cerenkov tomography, and for spectral unmixing in multimodal studies that involve both Cerenkov and bioluminescence signals, also will be characterized. Finally, we will estimate the light energy delivered to tissues by radiotracers via the Cerenkov effect, to determine if this mechanism can feasibly be used as a source of internal excitation for photoactivation. The anticipated outcome of this work is a detailed understanding of the production, distribution and transport of visible Cerenkov radiation by systemically-administered radiotracers, that will serve as a critical foundation on which to develop biomedical applications based on this newly-observed phenomenon.
PUBLIC HEALTH RELEVANCE: Radiotracers commonly administered for medical imaging examinations in nuclear medicine have recently been observed to emit detectable amounts of visible light via the Cerenkov effect. This opens up new opportunities for in vivo imaging of diagnostic and therapeutic radionuclides using sensitive optical imaging cameras, especially in preclinical small-animal studies. There also are prospects for using this Cerenkov radiation to assist in delivering light-activated therapies deep inside the body without the use of an external laser. This research in this proposal seeks to determine the feasibility of using Cerenkov light fo both imaging and therapeutic applications.
描述(由申请人提供):切伦科夫辐射是一种现象,当带电粒子在介电介质(如组织)中运动速度超过光速时,会发射光子。最近,我们和其他人发现,由于切伦科夫效应,可测量的可见光在体内服用?向小动物释放放射性核素。此外,产生可检测信号所需的注射活性量与小动物分子成像应用一致。这一观察结果导致了一种新的混合分子成像方式的发展,称为切伦科夫发光成像(CLI),它允许标记为?利用灵敏的电荷耦合器件(CCD)相机在体内对放射性核素进行成像。这对于具有重要治疗作用的临床前研究尤其有价值。-释放放射性核素,如90Y,在示踪剂剂量下使用任何其他体内成像技术都不容易成像。CLI还提供了一种快速、低成本、易于获取的方法来对小动物的PET放射性示踪剂进行成像。切伦科夫发光的转化机会也存在。CLI可能用于皮肤、眼睛和口腔,或者使用内窥镜或基于导管的体内设备。正在探索的另一种可能的应用是利用放射性示踪剂产生的丰富的蓝色/UV切伦科夫光作为组织内部光激活的内部光传递源,例如在光动力治疗和光激活药物传递中。本提案的目标是提供切伦科夫发光的定量理解,因为它适用于生物医学应用,并产生数据,作为指导小动物和分子成像和治疗界的切伦科夫转化应用开发的平台。具体目标是通过计算/模拟、模拟实验和体内研究的结合,获得对切伦科夫信号和光谱的详细定量理解。我们将比较两种不同的相机技术检测弱切伦科夫信号的性能,并确定检测极限。利用光谱信息进行切伦科夫层析成像的能力,以及在涉及切伦科夫和生物发光信号的多模态研究中进行光谱分解的能力,也将被描述。最后,我们将通过切伦科夫效应估计放射性示踪剂传递到组织的光能,以确定该机制是否可行地用作光激活的内部激发源。这项工作的预期结果是通过系统管理放射性示踪剂详细了解可见切伦科夫辐射的产生、分布和传输,这将作为基于这一新观察到的现象开发生物医学应用的关键基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Simon R Cherry其他文献
Functional whole-brain imaging in behaving rodents
行为啮齿动物的功能性全脑成像
- DOI:
10.1038/nmeth0411-301 - 发表时间:
2011-03-30 - 期刊:
- 影响因子:32.100
- 作者:
Simon R Cherry - 通讯作者:
Simon R Cherry
New PET technologies – embracing progress and pushing the limits
- DOI:
10.1007/s00259-021-05390-4 - 发表时间:
2021-06-03 - 期刊:
- 影响因子:7.600
- 作者:
Nicolas Aide;Charline Lasnon;Adam Kesner;Craig S Levin;Irene Buvat;Andrei Iagaru;Ken Hermann;Ramsey D Badawi;Simon R Cherry;Kevin M Bradley;Daniel R McGowan - 通讯作者:
Daniel R McGowan
Simon R Cherry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Simon R Cherry', 18)}}的其他基金
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
开发 PET 成像生物标志物来预测新型 H-NOX 氧载体增强的胶质母细胞瘤放疗
- 批准号:
9240463 - 财政年份:2017
- 资助金额:
$ 34.09万 - 项目类别:
Research at the interface of optical and ionizing radiation for innovative cancer imaging and therapy
用于创新癌症成像和治疗的光学和电离辐射界面研究
- 批准号:
9115570 - 财政年份:2015
- 资助金额:
$ 34.09万 - 项目类别:
Research at the interface of optical and ionizing radiation for innovative cancer imaging and therapy
用于创新癌症成像和治疗的光学和电离辐射界面研究
- 批准号:
10242140 - 财政年份:2015
- 资助金额:
$ 34.09万 - 项目类别:
Innovative Silicon Photomultiplier Technologies for Small-Animal PET
用于小动物 PET 的创新硅光电倍增技术
- 批准号:
9287788 - 财政年份:2015
- 资助金额:
$ 34.09万 - 项目类别:
Photodynamic Therapy Mediated by Cerenkov Light Emitted from Radiopharmaceut
放射性药物发出的切伦科夫光介导的光动力疗法
- 批准号:
8702867 - 财政年份:2014
- 资助金额:
$ 34.09万 - 项目类别:
A cost-effective high-performance ceramic garnet scintillator for PET
用于 PET 的经济高效的高性能陶瓷石榴石闪烁体
- 批准号:
8435109 - 财政年份:2012
- 资助金额:
$ 34.09万 - 项目类别:
A cost-effective high-performance ceramic garnet scintillator for PET
用于 PET 的经济高效的高性能陶瓷石榴石闪烁体
- 批准号:
8721957 - 财政年份:2012
- 资助金额:
$ 34.09万 - 项目类别:
A cost-effective high-performance ceramic garnet scintillator for PET
用于 PET 的经济高效的高性能陶瓷石榴石闪烁体
- 批准号:
8554763 - 财政年份:2012
- 资助金额:
$ 34.09万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.09万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.09万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.09万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.09万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.09万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.09万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.09万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.09万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.09万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.09万 - 项目类别:
Research Grant